Relief Therapeutics Holding (Relief Therapeutics Holding) Price-to-Operating-Cash-Flow : (As of Apr. 30, 2024)

View and export this data going back to 1990. Start your Free Trial

What is Relief Therapeutics Holding Price-to-Operating-Cash-Flow?

As of today (2024-04-30), Relief Therapeutics Holding's share price is $1.44. Relief Therapeutics Holding's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-1.99. Hence, Relief Therapeutics Holding's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Relief Therapeutics Holding's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Relief Therapeutics Holding's highest Price-to-Operating-Cash-Flow Ratio was 5.88. The lowest was 3.27. And the median was 4.57.

RLFTF's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.83
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Relief Therapeutics Holding's Cash Flow from Operations per share for the six months ended in Jun. 2023 was $-1.05. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-1.99.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -154.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -103.70% per year.

During the past 13 years, Relief Therapeutics Holding's highest 3-Year average Operating Cash Flow per Share Growth Rate was 96.30% per year. The lowest was -416.80% per year. And the median was -90.70% per year.

Relief Therapeutics Holding Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Relief Therapeutics Holding's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relief Therapeutics Holding Price-to-Operating-Cash-Flow Chart

Relief Therapeutics Holding Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Relief Therapeutics Holding Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Relief Therapeutics Holding's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Relief Therapeutics Holding's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Relief Therapeutics Holding's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Relief Therapeutics Holding's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Relief Therapeutics Holding's Price-to-Operating-Cash-Flow falls into.

Relief Therapeutics Holding Price-to-Operating-Cash-Flow Calculation

Relief Therapeutics Holding's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	1.44	/	-1.987
	=

Relief Therapeutics Holding's Share Price of today is $1.44.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Relief Therapeutics Holding's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-1.99.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Relief Therapeutics Holding Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Relief Therapeutics Holding (Relief Therapeutics Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (OTCPK:RLFTF) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

RLFTY:USA RLFz:UK RLF:Switzerland

Address

Avenue de Secheron 15, Fondation EIP, Batiment, Geneva, CHE, CH-1202

Website

https://www.relieftherapeutics.com

Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Geographically group generates the majority of its revenue from Europe.